In addition, Rosilio, et al. corroborated the observation that AMPK activation inhibits mTOR in T-ALL cells via the use of metformin, phenformin, and AICAR (5-Aminoimidazole-4-carboxamide ribonucleotide) [26]. Here, MTOR is linked to acute lymphoblastic leukemia.